Catalyst Capital Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-301
| Closed | -$12.5K | – | 501 |
|
|
2024
Q4 | $12.5K | Hold |
301
| – | – | ﹤0.01% | 470 |
|
|
2024
Q3 | $20.1K | Sell |
301
-69
| -19% | -$4.61K | ﹤0.01% | 448 |
|
|
2024
Q2 | $43.9K | Sell |
370
-3
| -0.8% | -$356 | ﹤0.01% | 255 |
|
|
2024
Q1 | $39.7K | Buy |
373
+16
| +4% | +$1.71K | ﹤0.01% | 261 |
|
|
2023
Q4 | $35.5K | Buy |
357
+75
| +27% | +$7.46K | ﹤0.01% | 240 |
|
|
2023
Q3 | $29.1K | Buy |
282
+69
| +32% | +$7.13K | ﹤0.01% | 282 |
|
|
2023
Q2 | $25.9K | Sell |
213
-13
| -6% | -$1.58K | ﹤0.01% | 293 |
|
|
2023
Q1 | $34.7K | Sell |
226
-74
| -25% | -$11.4K | ﹤0.01% | 261 |
|
|
2022
Q4 | $53.9K | Sell |
300
-12
| -4% | -$2.16K | ﹤0.01% | 250 |
|
|
2022
Q3 | $37K | Sell |
312
-10,372
| -97% | -$1.23M | ﹤0.01% | 274 |
|
|
2022
Q2 | $1.53M | Sell |
10,684
-221
| -2% | -$31.6K | 0.06% | 127 |
|
|
2022
Q1 | $1.88M | Buy |
10,905
+57
| +0.5% | +$9.82K | 0.08% | 131 |
|
|
2021
Q4 | $2.76M | Buy |
10,848
+10,606
| +4,383% | +$2.69M | 0.13% | 109 |
|
|
2021
Q3 | $93K | Sell |
242
-3
| -1% | -$1.15K | ﹤0.01% | 268 |
|
|
2021
Q2 | $58K | Buy |
245
+8
| +3% | +$1.89K | ﹤0.01% | 298 |
|
|
2021
Q1 | $31K | Sell |
237
-42
| -15% | -$5.49K | ﹤0.01% | 298 |
|
|
2020
Q4 | $29K | Buy |
+279
| New | +$29K | ﹤0.01% | 292 |
|
|
2019
Q2 | – | Sell |
-310
| Closed | -$6K | – | 451 |
|
|
2019
Q1 | $6K | Hold |
310
| – | – | ﹤0.01% | 343 |
|
|
2018
Q4 | $5K | Buy |
+310
| New | +$5K | ﹤0.01% | 360 |
|